GRCE - gracetx.com Qarzning balans kapitallashuviga nisbati
Grace Therapeutics, Inc. (GRCE) noyob nevropatologiyalar uchun davolash portfelini uzoq muddatli kengaytirishga e'tibor qaratgan. Ushbu tor ixtisoslashuv binariy xatarlarni yuzaga keltiradi, biroq ular kompaniyaning ishlanmalari noyobligi bilan yumshatiladi. Bunday dori vositalariga bo'lgan talab barqaror qolmoqda va iqtisodiy sharoitlardan mustaqildir. Kompaniyaning kitob kapitalizatsiyasiga nisbatan qarzi moliyaviy leverajni namoyish etadi, bunda 0.00 ushbu metrikaning joriy qiymatini belgilaydi.
%20Qarzning%20sof%20aktivlarga%20nisbati&width=1200&height=400&colorIndex=0&v=mvrk6wqv.ssk-7as46ww&start=20220704&end=20261028&filename=GURU_Markets_-_GRCE_-_Grace-Therapeutics-Inc._-_Debt-to-Net-Assets-Ratio "Grace Therapeutics, Inc. - GRCE Qarzning balans kapitallashuviga nisbati (davr: 29.10.2024 - 28.10.2026) | 👁️GURU.Markets👁️")
gracetx.com (GRCE) kompaniyasi koʻrsatkichlari kesimi va tahlili
- narx va narxlar bo'yicha konsensus prognoz:
- bozor kapitallashuvi bo'yicha ma'lumotlar:
- balans kapitallashuvi bo'yicha ma'lumotlar:
- qarz va likvidlik bo'yicha ma'lumotlar:
Qarzning xususiy kapitalga nisbati Grace Therapeutics, Inc.|GRCE - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Qisqa muddatli qarzning kapitalga nisbati Grace Therapeutics|GRCE - Kompaniyaning jamlangan qarzlari|Balans kapitallashuviga qarzlar GRCE|GRCE - Kompaniyaning uzoq muddatli majburiyatlari|Kompaniyaning qisqa muddatli qarzlari Grace Therapeutics
Kompaniyaning fundamental tahlili:Grace Tx (GRCE)
Ushbu ko'rsatkich kapitalga nisbatan korporativ kreditlashning kritik darajalarini aks ettiradi. Formula moliyaviy barqarorlikni baholash uchun balansdagi aktivlar tuzilmasi ichida umumiy majburiyatlarning ulushini aniqlaydi. Firma qarzdorligining kapitalizatsiyaga nisbati profilini tahlil qilish orqali investor defolt xatarlarini yoki resurslardan samarasiz foydalanishni aniqlashi mumkin. Ushbu koeffitsiyentning pasayishi to'lov xatarlarini minimallashtiradi, bu esa Grace Therapeutics, Inc. (GRCE) uchun kamyob markaziy nerv tizimi kasalliklari terapiyalarini tijoratlashtirishdan oldin juda muhimdir.
Grace Therapeutics, Inc. raqobatchilari
Qarzning balans qiymatiga nisbati BIIB (Biogen Inc.)|neurocrine.com - Balans kapitallashuviga qarzlar|Qarzning balans kapitallashuviga nisbati Regencell Bioscience Holdings Limited (RGC)|AXSM: Qarzning sof aktivlarga nisbati|Qarzning balans kapitallashuviga nisbati ACAD|Xenon Corp (XENE) - Balans qiymatiga qarzlar|Viking Therapeutics - Balans kapitallashuviga qarzlar|Qarzning sof aktivlarga nisbati SUPN|Catalyst Pharmaceuticals, Inc. (CPRX) - Qarzning balans kapitallashuviga nisbati|Qarzning sof aktivlarga nisbati Denali (DNLI)|Balans kapitallashuviga qarzlar HRMY (Harmony Pharma)|Balans kapitallashuviga qarzlar Biohaven Corp BHVN|AMLX: Balans kapitallashuviga qarzlar|TRVI - Qarzning balans qiymatiga nisbati|Balans kapitallashuviga qarzlar PRAX|Balans qiymatiga qarzlar Anavex|CBLL - Qarzning balans qiymatiga nisbati|Qarzning sof aktivlarga nisbati prothena.com (PRTA)|Qarzning balans qiymatiga nisbati Alector, Inc.|Qarzning balans kapitaliga nisbati annexonbio.com (ANNX)|Balans kapitallashuviga qarzlar Omeros|Qarzning sof aktivlarga nisbati Neurogene Inc NGNE|ACIU (AC Immune Corp) - Balans kapitallashuviga qarzlar|VYGR: Balans qiymatiga qarzlar|Qarzning balans kapitallashuviga nisbati Neumora Therapeutics NMRA|scilexholding.com (SCLX) - Qarzning sof aktivlarga nisbati|TVGN (Tevogen Bio) - Balans kapitallashuviga qarzlar|Balans kapitallashuviga qarzlar ACOG|CGTX - Qarzning balans kapitallashuviga nisbati|Qarzlarning balans kapitallashuviga nisbati Inhibikase Pharma (IKT)|SAVA: Balans kapitallashuviga qarzlar|ASRT - Balans qiymatiga qarzlar|Coya - Qarzning balans qiymatiga nisbati|Vistagen Therapeutics (VTGN) - Balans kapitallashuviga qarzlar|OVID - Qarzning balans qiymatiga nisbati|Acumen Pharmaceuticals, Inc (ABOS) - Qarzning balans kapitaliga nisbati|CRVO: Balans kapitallashuviga qarzlar|Sof aktivlarga qarzlar Alterity Therapeutics Ltd|Balans kapitallashuviga qarzlar CLNN (Clene Inc.)|Qarzning balans qiymatiga nisbati PEPG (pepgen.com)|Qarzning balans kapitallashuviga nisbati JUNS|RLMD - Sof aktivlarga qarzlar|Qarzning balans qiymatiga nisbati Annovis Bio, Inc. (ANVS)|AIFF - Qarzning sof aktivlarga nisbati|anewmeds.com - Balans kapitallashuviga qarzlar|NRSN (NeuroSense Therapeutics Ltd.) - Sof aktivlarga qarzlar|Qarzning balans kapitallashuviga nisbati Reviva Pharmaceuticals Holdings (RVPH)|Qarzning balans qiymatiga nisbati MetaVia, Inc.|Balans kapitallashuviga qarzlar NRXS (NeurAxis, Inc.)|Qarzning balans qiymatiga nisbati heliusmedical.com HSDT|Qarzning balans qiymatiga nisbati PASG|Sof aktivlarga qarzlar Neuphoria Therapeutics, Inc. NEUP|Balans kapitallashuviga qarzlar NERV|ATHA: Qarzning sof aktivlarga nisbati|Qarzning balans kapitallashuviga nisbati Addex Therapeutics ADXN|Alzamend Neuro (ALZN) - Qarzning sof aktivlarga nisbati|Balans kapitallashuviga qarzlar CYCN|Qarzning balans qiymatiga nisbati Protagenic|Pasithea Therapeutics - Balans kapitallashuviga qarzlar|Balans qiymatiga qarzlar CRGT (cortigent.com)|ATXI - Qarzning balans kapitallashuviga nisbati|Qarzning balans qiymatiga nisbati brainstorm-cell.com BCLI|CARA (Cara Therapeutics) - Balans kapitallashuviga qarzlar|Chromocell Therapeutics Corp (CHRO) - Balans qiymatiga qarzlar|ELYM: Qarzning balans qiymatiga nisbati|ITCI (Intra-Cellular Therapies, Inc.) - Balans kapitallashuviga qarzlar|LBPH - Qarzning balans kapitallashuviga nisbati|Qarzning sof aktivlarga nisbati MRNS|NKGen Biotech - Qarzning balans kapitallashuviga nisbati|Balans qiymatiga qarzlar NeuroBo Pharmaceuticals Inc (NRBO)|SAGE (Sage Therapeutics, Inc) - Balans kapitallashuviga qarzlar|Synaptogenix, Inc - Qarzning sof aktivlarga nisbati|Qarzning balans kapitallashuviga nisbati Trevena, Inc. (TRVN)|VIGL - Qarzning sof aktivlarga nisbati|WENA: Balans kapitallashuviga qarzlar|Cerevel Therapeutics Inc (CERE) - Balans kapitallashuviga qarzlar